This filing is part of the company’s quarterly result. Read the full results article, with every figure explained →
Paras Healthcare consolidated Sep 2026 quarter revenue up 23%, profit after tax up 226% year on year
PARASHLTH · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Minute windows have no benchmark: there is no intraday index history to compare against.
In the consolidated quarter ended 30 September 2026, revenue from operations rose 22.8% to INR 5,108.95 million from INR 4,161.25 million; profit after tax rose 225.7% to INR 403.50 million from INR 123.89 million a year earlier. Operating profit margin before interest, depreciation and tax improved from 19.6% to 23.5%. Borrowings were about 2.0 times equity. Six-month operating cash flow was positive at INR 681.71 million. The review was unmodified.
Strong growth may support the stock, but borrowings were 2.0 times equity at quarter-end and six-month operating cash flow fell year on year.
| Q2 FY27 | Year ago | Change | |
|---|---|---|---|
| Revenue | ₹510.9 Cr | — | — |
| Operating profit | ₹47.77 Cr | — | — |
| Profit after tax | ₹40.35 Cr | — | — |
| EBITDA margin | 23.5% | — | — |
From the company's XBRL filing, not from the text above. Operating profit = profit before tax − exceptional items − other income. EBITDA = profit before tax + finance costs + depreciation − other income. No year-ago figures on this basis yet, so no comparison.